These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 9347203

  • 1. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L.
    Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
    [Abstract] [Full Text] [Related]

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 3. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep 11; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 4. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD, Lawrenson RA.
    Am J Obstet Gynecol; 1998 Sep 11; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [Abstract] [Full Text] [Related]

  • 5. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ.
    Contraception; 1998 Feb 11; 57(2):67-70. PubMed ID: 9589831
    [Abstract] [Full Text] [Related]

  • 6. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 7. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.
    BMJ; 1997 Dec 06; 315(7121):1502-4. PubMed ID: 9420491
    [Abstract] [Full Text] [Related]

  • 8. The differential risk of oral contraceptives: the impact of full exposure history.
    Lewis MA, MacRae KD, Kühl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO.
    Hum Reprod; 1999 Jun 06; 14(6):1493-9. PubMed ID: 10359554
    [Abstract] [Full Text] [Related]

  • 9. The 1995 pill scare revisited: anatomy of a non-epidemic.
    Spitzer WO.
    Hum Reprod; 1997 Nov 06; 12(11):2347-57. PubMed ID: 9436662
    [Abstract] [Full Text] [Related]

  • 10. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP.
    Lancet; 1995 Dec 16; 346(8990):1593-6. PubMed ID: 7500751
    [Abstract] [Full Text] [Related]

  • 11. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR, Ory H.
    Contraception; 1997 May 16; 55(5):267-72. PubMed ID: 9220222
    [Abstract] [Full Text] [Related]

  • 12. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G, Kohlmeier L, Brenner H.
    Eur J Clin Nutr; 1998 Oct 16; 52(10):711-5. PubMed ID: 9805216
    [Abstract] [Full Text] [Related]

  • 13. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O.
    Am J Obstet Gynecol; 1999 Jun 16; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [Abstract] [Full Text] [Related]

  • 14. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr 16; 7(1):3-6. PubMed ID: 12320047
    [Abstract] [Full Text] [Related]

  • 15. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S, Spitzer WO, Rainville B, Cusson J, Lewis M, Heinemann L.
    Hum Reprod; 2000 Apr 16; 15(4):817-21. PubMed ID: 10739826
    [Abstract] [Full Text] [Related]

  • 16. 2 methods for prescribing third-generation OCs.
    Contracept Technol Update; 1997 Dec 16; 18(12):148-9. PubMed ID: 12348220
    [Abstract] [Full Text] [Related]

  • 17. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O.
    BMJ; 1993 Apr 10; 306(6883):956-63. PubMed ID: 8490470
    [Abstract] [Full Text] [Related]

  • 18. The risk of venous thromboembolism in users of postcoital contraceptive pills.
    Vasilakis C, Jick SS, Jick H.
    Contraception; 1999 Feb 10; 59(2):79-83. PubMed ID: 10361621
    [Abstract] [Full Text] [Related]

  • 19. Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making?
    Westhoff CL.
    Contraception; 1996 Jul 10; 54(1):1-3. PubMed ID: 8804800
    [Abstract] [Full Text] [Related]

  • 20. Third-generation oral contraceptives: how risky?
    Weiss N.
    Lancet; 1995 Dec 16; 346(8990):1570. PubMed ID: 7500743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.